IOVA - Iovance Biotherapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$4.00
DETAILS
HIGH:
$5.00
LOW:
$2.00
MEDIAN:
$5.00
CONSENSUS:
$4.00
DOWNSIDE:
0.99%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 8,016,353 | $28.1M | 0.0% | +4,186,558 | INCREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-06-16 | WEISER MICHAEL | director | A-Award | 90,316 | -- | -- |
| 2026-06-16 | Dukes Iain D. | director | A-Award | 180,632 | -- | -- |
| 2026-06-16 | Countouriotis Athena | director | A-Award | 90,316 | -- | -- |
| 2026-06-16 | Maynard Ryan D | director | A-Award | 90,316 | -- | -- |
| 2026-06-16 | Puri Raj K. | officer: Chief Regulatory Officer | A-Award | 15,000 | -- | -- |
| 2026-06-05 | Vogt Frederick G | director, officer: Interim CEO & General Counsel | F-InKind | 6,638 | $4.23 | $28K |
| 2026-06-05 | GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | F-InKind | 3,976 | $4.23 | $17K |
| 2026-06-05 | GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | M-Exempt | 7,813 | -- | -- |
| 2026-06-05 | BILINSKY IGOR | officer: Chief Operating Officer | F-InKind | 3,976 | $4.23 | $17K |
| 2026-06-05 | Puri Raj K. | officer: Chief Regulatory Officer | F-InKind | 3,843 | $4.23 | $16K |
| 2026-06-05 | Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 15,625 | -- | -- |
| 2026-06-05 | BILINSKY IGOR | officer: Chief Operating Officer | M-Exempt | 7,813 | -- | -- |
| 2026-06-05 | Puri Raj K. | officer: Chief Regulatory Officer | M-Exempt | 9,766 | -- | -- |
| 2026-06-01 | Puri Raj K. | officer: Chief Regulatory Officer | F-InKind | 2,508 | $3.96 | $10K |
| 2026-06-01 | GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | F-InKind | 4,473 | $3.96 | $18K |
| 2026-06-01 | GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | M-Exempt | 8,790 | -- | -- |
| 2026-06-01 | Vogt Frederick G | director, officer: Interim CEO & General Counsel | F-InKind | 17,701 | $3.96 | $70K |
| 2026-06-01 | BILINSKY IGOR | officer: Chief Operating Officer | M-Exempt | 8,790 | -- | -- |
| 2026-06-01 | BILINSKY IGOR | officer: Chief Operating Officer | F-InKind | 4,473 | $3.96 | $18K |
| 2026-06-01 | Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 41,668 | -- | -- |
| 2026-06-01 | Puri Raj K. | officer: Chief Regulatory Officer | M-Exempt | 5,469 | -- | -- |
| 2026-05-11 | Kirby Daniel Gordon | officer: Chief Commercial Officer | F-InKind | 2,435 | $3.70 | $9K |
| 2026-05-11 | Kirby Daniel Gordon | officer: Chief Commercial Officer | M-Exempt | 10,000 | -- | -- |
| 2026-03-09 | Kirby Daniel Gordon | officer: Chief Commercial Officer | A-Award | 132,200 | -- | -- |
| 2026-03-09 | Roche Corleen M. | officer: Chief Financial Officer | A-Award | 132,200 | -- | -- |